Fertility and Sterility
Volume 93, Issue 1 , Pages 79-88 , 1 January 2010

Predictive factors for pregnancy after intrauterine insemination (IUI): An analysis of 1038 cycles and a review of the literature

  • Philippe Merviel, M.D., Ph.D.

      Affiliations

    • Department of Gynecology, Obstetrics and Reproductive Medicine, Amiens University Medical Center, Amiens, France
    • Corresponding Author InformationReprint requests: Philippe Merviel, M.D., Ph.D., Department of Gynecology, Obstetrics and Reproductive Medicine, Amiens University Medical Center, 124 rue Camille Desmoulins, F-80054 Amiens cedex 1, France (FAX: 33-322-533-690).
    • ,
  • Marie Hélène Heraud, M.D.

      Affiliations

    • Department of Gynecology, Obstetrics and Reproductive Medicine, Amiens University Medical Center, Amiens, France
    • ,
  • Nadège Grenier, M.D.

      Affiliations

    • Department of Gynecology, Obstetrics and Reproductive Medicine, Amiens University Medical Center, Amiens, France
    • ,
  • Emmanuelle Lourdel, M.D.

      Affiliations

    • Department of Gynecology, Obstetrics and Reproductive Medicine, Amiens University Medical Center, Amiens, France
    • ,
  • Pierre Sanguinet, M.D.

      Affiliations

    • In Vitro Fertilization and Cytogenetics Laboratory, Amiens University Medical Center, Amiens, France
    • ,
  • Henri Copin, M.D., Ph.D.

      Affiliations

    • In Vitro Fertilization and Cytogenetics Laboratory, Amiens University Medical Center, Amiens, France

Received 7 September 2007 ,Revised 16 September 2008 ,Accepted 16 September 2008.

References 

  1. Annual report of the French Biomedicine Agency 2005. www.agence-biomedecine.fr.
  2. World Health Organization. Reference Values of Semen Variables. 4th ed. 1999.
  3. Penarrubia J, Balasch J, Fabregues F, Carmona F, Casamitjana R, Moreno V, et al. Day 5 inhibin serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment. Hum Reprod. 2000;15:1499–1504
  4. Nuojua-Huttunen S, Tomas C, Bloigu R, Tuomivaara L, Martikainen H. Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome. Hum Reprod. 1999;14:698–703
  5. Brzechffa PR, Daneshmand S, Buyalos RP. Sequential clomiphene citrate and human menopausal gonadotrophin with intrauterine insemination: the effect of patient age on clinical outcome. Hum Reprod. 1998;13:2110–2114
  6. Bronte A, Stone PD, Ringler GE, Stein AL, Marrs RP. Determinants of the outcome of intrauterine insemination: analysis of outcomes of 9963 consecutives cycles. Obstet Gynecol. 1999;180:1522–1564
  7. Goverde A, Vermeiden J, Schats R, Rutten F, Schomaker J. Intrauterine insemination or in-vitro fertilization in idiopathic subfertility: a randomised trial and cost effectiveness analysis. Lancet. 2000;355:13–17
  8. Mullin CM, Virji N, Saketos M, San Roman G. Day 2 Follicles stimulating hormone (FSH) and estradiol (E2): could these values be used as markers to predict pregnancy outcomes in women undergoing ovulation induction (OI) therapy with intrauterine insemination (IUI) cycles?. Fertil Steril. 2005;84:S162
  9. Collins JA, Willan AR. The prognosis for live birth among untreated infertile couples. Fertil Steril. 1995;64:22–28
  10. Snick HKA, Evers JLH, Collins JA. The spontaneous pregnancy prognosis in untreated subfertile couples: the Walcheren primary care study. Hum Reprod. 1997;12:1582–1588
  11. Dodson WC, Legros RS. The effect of obesity on treatment outcomes for infertile ovulatory women undergoing superovulation and intrauterine insemination. Fertil Steril. 2005;84:S72–S73
  12. Hassan MA, Killick SR. Negative lifestyle is associated with a significant reduction in fecundity. Fertil Steril. 2004;81:384–392
  13. Gallot-Lavallée P, Ecochard R, Mathieu C, Pinzaru G, Czyba JC. Clomiphene citrate or hMG: which ovarian stimulation to chose before intrauterine inseminations? A meta-analysis. Contracept Fertil Sex. 1995;23:115–121
  14. Steures P, Van der Veen F, Hompes PG, Eijkemans MI, Mol BW. A randomized clinical trial assessing the effectiveness of intrauterine insemination for couples with an isolated cervical factor. Fertil Steril. 2005;84:S54
  15. Massin N, Cedrin-Durnerin I, Hugues JN. Intrauterine insemination: a spontaneous or medically-assisted ovulation?. Gynecol Obstet. 2004;32:898–903
  16. Vlahos N, Lawlera C, Zhai Y, Bankowski B, Wallach E. Women with ovulatory dysfunction undergoing ovarian stimulation with clomiphene citrate for intrauterine insemination may benefit from administration of human chorionic gonadotropin. Fertil Steril. 2005;83:1510–1516
  17. Dickey PR, Taylor SN, Lu PY, Sartop B, Rye P, Pyrzak R. Effect of diagnoses, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrate intrauterine insemination. Fertil Steril. 2002;78:1088–1095
  18. Belaisch-Allart J, Mayenga JM, Plachot M. Intrauterine insemination. Contracept Fertil Sex. 1999;27:616–621
  19. Jansen RP. Minimal endometriosis and reduced fecundability: prospective evidence from an artificial insemination by donor program. Fertil Steril. 1986;46:141–143
  20. Toma SK, Hammond MG. The effect of laparoscopic ablation or danocrine on pregnancy rates in patients with stage I or II endometriosis undergoing donor insemination. Obstet Gynecol. 1992;80:253–256
  21. Prado-Perez J, Perez-Rivadeneira E, Sanon-Julien F. The impact of endometriosis on the rate of pregnancy of patients submitted to intrauterine insemination. Fertil Steril. 2002;77:S51
  22. Surrey ES, Halme J. Endometriosis as a cause of infertility. Obstet Gynecol Clin N Am. 1989;16:79–91
  23. Shapiro DB, Algert C, Thornton KL, Nulsen JC. Endometrial thickness in women with endometriosis or unexplained infertility undergoing superovulation with intrauterine insemination. J Soc Gynecol Invest. 1995;2:367
  24. Dmowski WP, Pry M, Ding J, Rana N. Cycle-specific and cumulative fecundity in patients with endometriosis who are undergoing controlled ovarian hyperstimulation-intrauterine insemination or in vitro fertilization-embryo transfer. Fertil Steril. 2002;78:750–756
  25. Nulsen JC, Dumeez S, Metzger DA. A randomized and longitudinal study of human menopausal gonadotropin with intrauterine insemination in the treatment of infertility. Obstet Gynecol. 1993;82:780–786
  26. Tummon IS, Martin JS, Tulandi T. Randomized controlled trial of superovulation and 1 insemination for infertility associated with minimal or mild endometriosis. Fertil Steril. 1997;68:8–12
  27. Sakhel K, Schwarck S, Ashraf M, Abuzeid M. Semen parameters as determinants of success in 1662 cycles of intrauterine insemination after controlled ovarian hyperstimulation. Fertil Steril. 2005;84:248–249
  28. Burr R, Siegberg R, Matthews C, Flaherty S. The influence of sperm morphology and the number of motile sperm inseminated on the outcome of intrauterine insemination combined with mild ovarian stimulation. Fertil Steril. 1996;65:127–132
  29. Karabinus DS. The impact of sperm morphology evaluated by strict criteria on intrauterine insemination success. Fertil Steril. 1997;67:536–541
  30. Wainer R, Albert M, Dorion A, Bailly M, Bergere M, Lombroso R, et al. Influence of the number of motile spermatozoa inseminated and their morphology on the success of intra-uterine insemination. Hum Reprod. 2004;19:2060–2065
  31. Miller DC, Smith GD, Randolph JF, Christman GM, Smith YR. Processed total motile sperm count correlates with pregnancy outcome after intra-uterine insemination. Urology. 2002;60:497–501
  32. Dickey RP, Lu PY, Taylor SN, Rye PH. Comparison of the sperm quality necessary for successful intra-uterine insemination with World Health Organization threshold values for normal sperm. Fertil Steril. 1999;71:684–689
  33. Horvath PM, Shelden RM, Kemmann E. The relationship of sperm parameters to cycle fecundity in superovulated women undergoing intrauterine insemination. Fertil Steril. 1989;52:288–294
  34. Van Voorhis BJ, Barnett M, Sparks AE, Syrop CH, Rosenthal G, Dawson J. Effect of the total motile sperm count on the efficacy and cost-effectiveness of intrauterine insemination and in vitro fertilization. Fertil Steril. 2001;75:661–668
  35. Huang HY, Lai YM. The impact of the total motile sperm count on the success of intrauterine insemination with husband's spermatozoa. J Assist Reprod Genet. 1996;13:56–63
  36. Campan A, Stalberg A, Bianchi PG, Comte I, Pache T, Walker D. Intrauterine insemination evaluation of results according to woman's age, sperm quality, total sperm count per insemination and life table analysis. Hum Reprod. 1996;11:732–736
  37. Aboulghar M, Mansour R, Serour G, Abdrazek A, Amin Y, Rhodes C. Controlled ovarian hyperstimulation and intrauterine insemination for treatment of unexplained infertility should be limited to a maximum of three trials. Fertil Steril. 2001;75:88–91
  38. Hughes EG. The effectiveness of ovulation induction and intra-uterine insemination in the treatment of persistent infertility: a meta-analysis. Hum Reprod. 1997;12:1865–1872
  39. Guzyck DS, Sullivan MW, Adamson GD, Cedars MI, Falk RJ, Peterson EP, et al. Efficacy of treatment for unexplained infertility. Fertil Steril. 1998;70:207–213
  40. Colhen BJ, Vandekerckhove P, te Velde ER, Habbema JD. Timed intercourse versus intra-uterine insemination with or without ovarian hyperstimulation for subfertility in men. Cochrane Database Syst Rev. 2000;(2):CD000360
  41. Collins J. Stimulated intrauterine insemination is not a natural choice for the treatment of unexplained subfertility. Current best evidence for the advanced treatment of unexplained subfertility. Hum Reprod. 2003;18:907–912
  42. Hughes EG. Stimulated intrauterine insemination is not a natural choice for the treatment of unexplained subfertility. “Effective treatment” or “not a natural choice”?. Hum Reprod. 2003;18:903–914
  43. Pandian Z, Nikolaou D, Vale L, Templeton A. The effectiveness of IVF in unexplained infertility: a systematic Cochrane review. 2002. Hum Reprod. 2003;18:2001–2007
  44. Dickey R, Taylor S, Curole D, Rye P. Sequential clomifene citrate and human menopausal gonadotrophin for ovulation induction: comparison to clomiphene citrate alone and human menopausal gonadotrophin alone. Hum Reprod. 1993;8:56–59
  45. Mangianiello P, Stukel T, Crow H, Bink-Johnses T, Weiss JA. Comparison of clomiphene citrate and human menopausal gonadotropin for use in conjunction with intrauterine insemination. Fertil Steril. 1997;66:405–442
  46. Stan W, De Vane G, Yeko T, Kipersztok S, Rhoton-Vlazack A, Sistrom C. A randomized, multicenter study comparing the efficacy of recombinant FSH vs recombinant FSH with Ganirelix during superovulation/IUI therapy. Am J Obstet Gynecol. 2004;191:648–651
  47. Checa M, Robles A, Carreras R. Use of gonadotropin-releasing hormone antagonist to overcome the drawbacks of intra-uterine insemination on weekends. Fertil Steril. 2006;85:573–577
  48. Plosker S, Amato P. Predicting and optimizing success in an intra-uterine stimulation program. Hum Reprod. 1994;9:2014–2021
  49. Jakus S, Spandorfer S, Rosenwaks Z. Natural cycle and timing of intrauterine insemination: HCG vs spontaneous LH surge. Fertil Steril. 2005;84:366–367
  50. Noyes N, Liu HC, Sultan KS, Schattmen G, Rozenwaks Z. Endometrial thickness appears to be a significant factor in embryo implantation in vitro fertilization. Hum Reprod. 1995;10:919–922
  51. Kovacs P, Boda K, Kaali SG. The effect of endometrial thickness on IVF/ICSI outcome. Hum Reprod. 2003;18:2337–2341
  52. Weissman A, Casper RF. The detrimental effect of increased endometrial thickness on implantation and pregnancy rates and outcome in an in vitro fertilization program. Fertil Steril. 1999;71:147–149
  53. De Geyter C, De Geyter M, Nieschlag E, Holzgreve W, Schneider HP. Prospective evaluation of the ultrasound appearance of the endometrium in a cohort of 1,186 infertile women. Fertil Steril. 2000;73:106–113
  54. Puerto B, Carmona F, Civco S, Vanrell JA, Balasch J. Ultrasonography as a predictor of embryo implantation after in vitro fertilization: a controlled study. Fertil Steril. 2003;79:1015–1022
  55. Yuval Y, Dor J, Achiron R. The relationships between endometrial thickness, and blood flow and pregnancy rates in in vitro fertilization. Hum Reprod. 1999;14:1067–1071
  56. Coulam CB, Soenksen DM, Britten S. Ultrasonographic predictors of implantation after assisted reproduction. Fertil Steril. 1994;62:1004–1010
  57. Schild RL, Eschweiler S, Van Der Ven H, Fimmers R, Hansmann M. Three dimensional endometrial volume calculation and pregnancy rate in an in vitro fertilization programme. Hum Reprod. 1999;14:1255–1258
  58. Kupesic S. Three-dimensional ultrasonographic uterine vascularization and embryo implantation. J Gynecol Obstet Biol Reprod. 2004;33:S18–S20
  59. Kolibianas EM, Zikopoulos KA, Fatemi HM, Osmanagaoglu K, Evenpoel J, Van Steirteghem A, et al. Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for intrauterine insemination. Reprod Biomed Online. 2004;8:115–118
  60. Wood EG, Go KJ, Gutman JN, Corson SL. Ultrasound-guided soft catheter embryo transfers will improve pregnancy rates in vitro fertilization. Hum Reprod. 2000;15:107–112
  61. Smith KL, O'Shea L, Arny M. Does catheter type affect pregnancy rates in intrauterine insemination cycles?. J Assist Reprod Genet. 2002;19:49–52
  62. Spiessens C, Debrock S, Meeuwis L, Bakelants E, Meuleman C. The type of catheter has no impact on the pregnancy rate after intrauterin insemination: a randomized study. Hum Reprod. 2003;18:S75
  63. Lavie O, Geva-Eldar T, Ben-Chetrit A. Ultrasonographic endometrial changes after intra-uterine insemination: comparison of two catheters. Fertil Steril. 1997;68:731–734
  64. Miller PB, Acres ML, Proctor JG, Higdon HL, Boone WR. Flexible versus rigid intra-uterine insemination catheters: a prospective, randomized, controlled study. Fertil Steril. 2005;83:1544–1546
  65. Tur R, Corleu B, Buxaderas R, Martinez F, Balasch J. Risk factors for high-order multiple implantation after ovarian stimulation with gonadotrophins: evidence from a large series of 1878 consecutive pregnancies in a single centre. Hum Reprod. 2001;16:2124–2129

 P.M. has nothing to disclose. M.H.H. has nothing to disclose. N.G. has nothing to disclose. E.L. has nothing to disclose. P.S. has nothing to disclose. H.C. has nothing to disclose.

PII: S0015-0282(08)04051-X

doi: 10.1016/j.fertnstert.2008.09.058

Fertility and Sterility
Volume 93, Issue 1 , Pages 79-88 , 1 January 2010

Article Tools